头颈癌幸存者低剂量CT与胸片筛查后第二原发肺癌发生率
该研究为随机临床试验的事后二次分析,从国家肺癌筛查试验中识别171例头颈癌幸存者,比较低剂量CT与胸片筛查后第二原发肺癌发生率。头颈癌幸存者肺癌发生率显著高于无头颈癌者(2080 vs 609/10万人年,校正率比2.54)。两组第二原发肺癌发生率及总生存无显著差异,但结果提示头颈癌幸存者属高危人群,应重视低剂量CT筛查。
要点
- 头颈癌幸存者肺癌发生率显著高于无头颈癌者,校正率比2.54。
- 低剂量CT组第二原发肺癌发生率为2610/10万人年,胸片组为1594/10万人年,差异无统计学意义。
核心结论
- 头颈癌幸存者发生第二原发肺癌的风险尤其高,应重视对吸烟史显著且适合根治性治疗者的低剂量CT筛查。
研究设计与样本
- 随机临床试验的事后二次分析,数据来自国家肺癌筛查试验(2002年8月至2004年4月入组)。
- 参与者平均年龄61岁(标准差5),男性132例(77.2%)。
主要发现
- 头颈癌幸存者肺癌发生率为2080/10万人年(2.1%),无头颈癌者为609/10万人年(0.6%),校正率比2.54(95%CI 1.63-3.95)。
- 头颈癌幸存者中,低剂量CT组第二原发肺癌发生率为2610/10万人年,胸片组为1594/10万人年,率比1.55(95%CI 0.59-3.63)。
临床怎么用
- 对具有显著吸烟史且适合根治性治疗的头颈癌幸存者,应考虑低剂量CT肺癌筛查。
局限性
- 本研究为事后二次分析,头颈癌幸存者样本量较小(171例),结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In head and neck cancer survivors, lung cancer screening may aid in detecting a second primary lung cancer or metastatic head and neck cancer earlier in the course of disease, which may improve treatment outcomes. However, no randomized data exist to assess the value of lung cancer screening in this population. OBJECTIVE: To evaluate the incidence of second primary lung cancer in survivors of head and neck cancer survivors with screening low-dose computed tomography (CT) vs chest radiography (CXR). DESIGN, SETTING AND PARTICIPANTS: For this ad hoc secondary analysis of a randomized clinical trial, head and neck cancer survivors were identified from the National Lung Screening Trial, which enrolled participants from August 2002 to April 2004. This randomized clinical trial compared screening using low-dose CT chest vs CXR in patients aged 55 to 74 years with at least a 30 pack-year history of cigarette smoking and who were current smokers or had quit within the past 15 years and who were at high risk for lung cancer. The incidences of second primary lung cancer and second primary head and neck cancer were compared with screening using low-dose CT vs CXR. Data were analyzed from December 1, 2020, to June 30, 2021. INTERVENTIONS: Screening low-dose CT of the chest vs CXR. MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of a second primary lung cancer. RESULTS: Among 53 452 enrolled participants, we identified 171 survivors of head and neck cancer, of whom 82 were screened with low-dose CT of the chest and 89 with CXR. Participants' mean (SD) age was 61 (5) years, and 132 were men (77.2%). The incidence of lung cancer was higher among head and neck cancer survivors compared with participants without head and neck cancer (2080 per 100 000 person-years [2.1%] vs 609 per 100 000 person-years [0.6%]; adjusted rate ratio, 2.54; 95% CI, 1.63-3.95). In head and neck cancer survivors, the incidence of second primary lung cancer was 2610 cases per 100 000 person-years in the low-dose CT group vs 1594 cases per 100 000 person-years in the CXR group (rate ratio, 1.55; 95% CI, 0.59-3.63). In head and neck cancer survivors, overall survival was 7.07 years with low-dose CT vs 6.66 years with CXR (log-rank P = .48). CONCLUSIONS AND RELEVANCE: The results of this ad hoc secondary analysis of a randomized clinical trial suggest that head and neck cancer survivors are at especially high risk for a second primary lung cancer. These findings underscore the importance of low-dose CT screening in head and neck cancer survivors with significant cigarette smoking history who are fit to undergo treatment with curative intent.
引用
- Cramer JD, Grauer J, Sukari A, et al. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34709369. doi:10.1001/jamaoto.2021.2776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。